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Need for services for the care and prevention of congenital 
disorders in South Africa as the country’s epidemiological 
transition evolves
The lack of prioritisation of congenital disorders 
(CDs) in health care, and the limited resources 
allocated to prevention and to the care of those 
affected, is an issue of global concern. This is 
especially true in low- and middle-income countries 
(LMICs), where over 90% of CDs currently occur, resulting in 95% of 
CD deaths worldwide.[1,2]
In 2010 the World Health Organization’s World Health Assembly 
(WHA) prioritised services for the care and prevention of CDs, 
particularly in LMICs, by passing Resolution WHA63.17.[2] This 
recognised the importance of CDs as a cause of stillbirths and 
neonatal deaths, their contribution to under-5 mortality, and their 
contribution to failure to attain Millennium Development Goal 4 
(MDG4). WHA63.17 urged member states to recognise and address 
CDs as a public health issue. It also highlighted the lack of accurate 
epidemiological data available for many LMICs.[2] CDs are often 
undiagnosed or misdiagnosed and the cause of death wrongly 
attributed. Collectively, this prevents policy decision-makers from 
correctly assessing the burden of CDs in these LMICs.[3]
In South Africa (SA), the constitutional, legal and regulatory 
framework exists to promote the development of services for the care 
and prevention of CDs. It is the government’s responsibility to provide 
such services. To understand the renewed need for these services, it 
is important to consider, contemplate and review the epidemiological 
transition that has occurred in SA over the last 25 years.
Epidemiology of CDs in SA
Modelled data of genetic causes of CDs[1] and an estimate of 
teratogenic causes (A L Christianson, personal communication, 
2014) indicate that a minimum of 6.8% of births, representing one 
in every 15 live births in SA, is affected by a CD. Of these, 80.5% 
are genetic or partially genetic in cause, while 19.5% are caused by 
teratogens. The latter is higher than the 10 - 15% expected, owing to 
the high prevalence of fetal alcohol syndrome.[1] With 26.2% of CDs 
diagnosable in the first day of life, over 18 000 cases annually should 
be identified and reported in SA.[4] However, in 2012 only 2 174 CDs 
were reported via the Birth Defects Collection Tool administered 
by the National Department of Health (NDoH) (V  Mtyongwe, 
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personal communication, 2013). This indicates under-reporting 
of 88%!
Although serious CDs can be life threatening or result in long-
term disability, up to 70% can be prevented, cured or ameliorated 
by appropriate care.[1,5] Many interventions are relatively inexpensive 
and low-tech, including surgery for congenital malformations and 
community-based preventive measures (e.g. iodine and folic acid 
fortification of staple foods).[1]
Epidemiological transition
Epidemiological transition is the term for the change in population 
health statistics and pattern of diseases of a country or region, 
consequent on change in socioeconomic, education, infrastructure 
and healthcare development.[1] Omran’s three-stage model of epi-
demiological transition[6] has been used extensively to describe 
this process, particularly in industrialised nations. During this 
transition, infant and child mortality rates decrease and longevity 
rises, communicable diseases are controlled and eradicated, and non-
communicable and degenerative diseases emerge.
Most high-income or industrialised countries completed the first 
two stages of epidemiological transition decades ago. Stage one, the 
‘age of pestilence and famine’, is characterised by high fluctuating 
mortality rates, a low life expectancy at birth, and epidemics, 
famine and war as the main causes of death. This is followed by 
stage two, the ‘age of receding pandemics’, when mortal ity starts to 
decrease and is accompanied by a marked increase in life expec-
tancy, although high levels of communicable disease re main.[6] 
By controlling infectious diseases, reducing malnutrition and 
improving healthcare (including maternal) services, industrialised 
countries moved into stage three, the ‘age of degenerative and 
man-made diseases’.[1,6] Deaths from CDs remain invisible during 
this process of transition  – ‘buried’ among deaths caused by 
communicable diseases – to emerge only as the latter are adequately 
controlled. CDs then become proportionately more significant in 
overall neonatal, infant and child mortality.
CDs attained public health significance in industrialised nations 
as they moved into the third stage of epidemiological transition 
in the early 1960s.[1] Since 85 - 90% of CDs have a genetic cause, 
their birth prevalence and resulting mortality remained high,[1]
causing them to emerge and persist as a leading cause of child 
death in industria lised nations. A comparative study of death 
rates in England and Wales for 1901 and 1971 demonstrates this: a 
68% reduction in non-communicable diseases occurred between 
1901 and 1971, but the number of deaths caused by CDs remained 
un changed.[1]
Epidemiological transition and CDs  
in SA
SA, like many LMICs, has not followed the classic model of 
epidemiological transition experienced by industrialised nations, 
as a result of the HIV/AIDS and TB epidemics.[7] Fig. 1 plots the 
under-5 mortality rate (U5MR), infant mortality rate (IMR) and life 
expectancy at birth (longevity) data for SA over the past 25 years. 
From 1960, a clear trend of decreasing infant and under-5 mortality 
and increasing longevity continued until 1992, when life expectancy 
at birth peaked at 62.33 years. In 1993, both the U5MR and the IMR 
were at an all-time low of 58.2/1 000 live births and 45.1/1 000 live 
births, respectively. At this point it appeared as if SA would follow 
the three classic stages of epidemiological transition, approaching 
the early phases of transition from stage two of the ‘age of receding 
pandemics’ to stage three, the ‘age of degenerative and man-made 
diseases’.[6]
As a result of this falling childhood mortality in the early 1990s, 
CDs began to emerge as a public health issue. The Policy Guidelines 
for the Management and Prevention of Genetic Disorders, Birth 
Defects and Disabilities were published by the NDoH in 2001.[8] 
These outlined goals, objectives, strategies and delivery of clinical 
and laboratory services appropriate for the care and prevention of 
CDs. In 2004, the National Guidelines for the Care and Prevention of 
the Most Common Genetic Disorders, Birth Defects and Disabilities[9] 
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Fig. 1. Epidemiological transition in SA over the past 25 years, as demonstrated by data for childhood mortality,[18] longevity[19] and the HIV epidemic.[20]
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were published, targeting primary healthcare providers, describing 
common CDs and strategies for their care and prevention. However, 
progress in epidemiological transition was dramatically interrupted 
and reversed in the mid-1990s with the advent of the concomitant 
HIV/AIDS and TB epidemics (Fig. 1). Over a 10-year period, HIV 
prevalence in pregnant women soared from 7.6% in 1994 to 29.5% 
in 2004. Child mortality rose dramatically, with the U5MR peaking 
at 80.8/1 000 live births in 2003 and the IMR at 53.2/1 000 in 2002. 
Life expectancy dropped to 51.56 years in 2005, an all-time low 
since the 1960s. SA was no longer following the sequential stages of 
transi tion as HIV/AIDS caused the resurgence of TB, adding a stage 
to Omran’s concept known as the ‘age of emergent and re-emergent 
infections’.[7,10,11] Combined with the simultaneously increasing 
burden of non-communicable diseases in the population, this has 
led to a ‘double burden of disease’.[11]
In 2004, the prevalence of HIV infection among pregnant women 
plateaued at 30% and the U5MR started to reduce as a result of scaled-
up prevention of mother-to-child transmission and expanded roll-
out of antiretroviral (ARV) therapy.[12] The 2002 IMR of 53.2/1 000 
live births dropped to 33.5 in 2012 (Fig. 1). This is lower than the 
all-time best IMR of 45/1 000 live births in 1993 prior to the HIV/
AIDS epidemic. However, since 2011 both the IMR and U5MR have 
stagnated without significant further reductions.[13]
A major effect of the HIV/AIDS and TB epidemics was to ‘bury’ 
the issue of CDs. As services for HIV/AIDS developed, funding and 
attention were diverted away from tertiary medical genetic services. 
If child mortality, including neonatal deaths, is to decrease further, 
control of these ongoing epidemics cannot be at the expense of other 
child healthcare needs.[12]
Services for the care and prevention of CDs in SA are now at a 
lower base than in 2001. The 2003 recommendations for human 
capacity requirements to be trained and in-post by 2010 to meet 
the expected, and now increased, health needs remain unful-
filled.[14] Personnel levels are similar to, or lower than, those in 2001, 
with 11 medical geneticists today compared with four in 2001 and 
the 20 recommended by 2010.[14] Of the nine genetic counsellors in 
posts today, only four are in the state system (T Wessels, personal 
communication, 2014), compared with approximately 20 in 2001, 
and the 80 recommended.[14] Budget cuts have compromised medical 
genetic diagnostic laboratory services countrywide.
In 2013, SA was reported as the only country of eight emerg ing 
economies evaluated where positive development in improv ing med-
ical genetic service structures had ceased and indeed regressed.[3] This 
decline will take time to reverse, and the dire state of these services, 
including the lack of policy addressing childhood disability, must be 
recognised by those in authority and urgently rectified.
Conclusion
While SA has missed attaining MDG4, it has significantly reduced 
the U5MR and IMR under difficult circumstances. The previous 
negative epidemiological transition, premised on the HIV/AIDS 
epidemic, has reversed and is once again positive with an IMR of 
33/1 000 live births.[7] SA must now confront the issue of developing 
services for the care and prevention of CDs to reduce the stagnating 
child mortality rates.[13] The current IMR is now below 40/1 000 live 
births, at which point countries recognise the coming health needs of 
CDs and strive to implement appropriate services.[15] The proportion 
of deaths from CDs in SA under-5s was 4% in 2008,[3] and may be 
expected to rise as childhood deaths from CDs increasingly emerge 
as a leading cause of death in children while deaths from infections, 
particularly HIV/AIDS, decrease.
Legislation entitles those affected and living with CDs, including 
those disabled as a result, to the ‘best possible patient care’ in the 
prevailing circumstances, and provides for access to prevention by 
appropriate interventions.[16] With the global focus, including that of SA, 
shifting to non-communicable diseases, CDs must be con textualised as 
the first non-communicable disease experienced by people. CDs deserve 
to be prioritised, in accordance with WHA Resolution WHA63.17, to 
ensure the human dignity and con stitutionally and legally enshrined 
human rights of those affected and their families.[2,17]
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